By using this site, you agree to the Privacy Policy and Terms of Use.
Accept

Parami News

  • Home
  • Politics
  • India
  • World
  • Business
  • Entertainment
  • Regional
  • Sports
  • Web Stories
Search
© 2024 Parami News. All Rights Reserved.
Reading: Clinical trial: Government announces waiver for several drugs approved from select countries | Parami News
Share
Sign In
Notification Show More
Font ResizerAa

Parami News

Font ResizerAa
Search
  • Home
  • Politics
  • India
  • World
  • Business
  • Entertainment
  • Regional
  • Sports
  • Web Stories
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Parami News > Blog > India > Clinical trial: Government announces waiver for several drugs approved from select countries | Parami News
India

Clinical trial: Government announces waiver for several drugs approved from select countries | Parami News

Atulya Shivam Pandey
Last updated: August 8, 2024 3:25 pm
Atulya Shivam Pandey
Share
3 Min Read
Clinical trial: Government announces waiver for several drugs approved from select countries | Parami News
SHARE

To facilitate the availability and lower the cost of foreign manufactured drugs in India, the Central Government has waived the requirement for clinical trials to be held in that country if such drugs have been approved by the health regulators of USA, UK, Japan, Australia, Canada, or European Union countries.

For new drug categories to be considered for Indian market by The Central Government specified 5 categories. “The waiver will include medicines including vaccines falling under certain categories like orphan drugs for rare diseases; gene & cellular therapy products; new drugs used in pandemic situations; new drugs used for special defense purposes; and new drugs with significant therapeutic advances over current standard care,” a senior Health Ministry official said adding that other countries may also be included or removed from this list.

This follows an order of August 7 issued by India’s drug regulatory agency – Central Drugs Standard Control Organisation (CDSCO), which has authorised the exemption of local clinical trials as regards approval of new drugs ‘as per Rule 101’.

The report reads: “(the) Central Licensing Authority under Rule 101 of New Drugs and Clinical Trial Rules, 2019 with approval of Central Government may from time to time specify by order name of countries for considering waiver of local clinical trial for approval of new drugs under Chapter X and grant permission for conduct of clinical trial under Chapter V of the said rules’’.

However, according to another ministry official, this has been a long-standing demand both from pharmaceutical companies and health experts advocating improved drug accessibility for patients as well as research initiatives.

Further commenting on this statement Anil Matai, director general Organization of Pharmaceutical Producers Of India (OPPI) described this step as positive one forward that will help Indian manufacturers and foreign drug makers get government approvals quickly thereby ensuring fast access to vital medicines in India.

What is wrong with India’s registry on clinical trials?

“OPPI has been avidly supportive about this notification since we believe it can completely change the pharmaceutical and healthcare space in this country. These are for special defense purposes, new drugs used for pandemics, orphan drugs for rare diseases, gene and cell-based therapy products, and new drugs with significant therapeutic advance over the current standard care,” he said. “This strategic alignment is particularly crucial for accelerating access to innovative therapies to the patients in India.’’

However, as much as this group maintains that these waivers should be extended to more categories of treatment options, it is asking the Central Government to consider other areas in need of such waivers but could significantly impact on patient access.

You Might Also Like

Graduation ceremony held for university colleges of engineering students

Staff of A.P. Raj Bhavan participate in Sankranthi celebrations

Two dozen workers trapped in Kannauj railway station building collapse

Bihar’s first sports university gets UGC recognition

Singer P. Jayachandran cremated with State honours in Chendamangalam

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Watch: Protesters try to disrupt Kamala Harris’s speech in Michigan. How she shut them down | Parami News Watch: Protesters try to disrupt Kamala Harris’s speech in Michigan. How she shut them down | Parami News
Next Article Paris Olympics 2024 Day 13, August 8: India’s Full Schedule | Parami News Paris Olympics 2024 Day 13, August 8: India’s Full Schedule | Parami News
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
136kSubscribersSubscribe
4.4kFollowersFollow

Latest News

Harry Meghan LA Fire Victims: Major outrage over Harry-Meghan’s visit to LA fire victims: ‘You are not royals…merely two nitwit celebrities’
Harry Meghan LA Fire Victims: Major outrage over Harry-Meghan’s visit to LA fire victims: ‘You are not royals…merely two nitwit celebrities’
World January 11, 2025
‘My chapter is over’: Bangladesh veteran Tamim Iqbal retires from international cricket | Cricket News
‘My chapter is over’: Bangladesh veteran Tamim Iqbal retires from international cricket | Cricket News
Sports January 11, 2025
Pakistan anti-terrorism court grants bail to more than 150 workers of Imran Khan’s party

 | Parami News
Pakistan anti-terrorism court grants bail to more than 150 workers of Imran Khan’s party | Parami News
Most Recent Stories January 11, 2025
Virat Kohli and Rohit Sharma will find form again, says England pacer Tymal Mills | Cricket News
Virat Kohli and Rohit Sharma will find form again, says England pacer Tymal Mills | Cricket News
Sports January 11, 2025
//

We influence 20 million users and is the number one business and technology news network on the planet

Quick Link

  • About Us
  • Contact Us
  • Advertise With Us
  • DNPA Code of Ethics
  • Disclaimer
  • Privacy Policy

Top Categories

  • Business
  • Entertainment
  • India
  • Politics
  • Regional
  • Sports

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Follow US
© 2024 Parami News. All Rights Reserved.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Welcome Back!

Sign in to your account

Lost your password?